Connect with us

Technology

Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency

Published

on

Collaboration will harness Medidata Electronic Clinical Outcome Assessment (eCOA) for remote patient engagement and real-time data capture

SINGAPORE, Feb. 29, 2024 /PRNewswire/ — Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, and Sanofi Vaccines, today announced a collaboration to harness Medidata eCOA to deploy in vaccine studies. This builds on Medidata and Sanofi’s longstanding, successful experience using Medidata Rave EDC (electronic data capture).

The collaboration will use an eDiary function within eCOA to create an eDiary library specific to Sanofi’s vaccines. This library will accelerate future study set-up times, improve efficiency, and increase data quality, while ensuring patients have access to eDiaries that are easy to use.

Sanofi has chosen to adopt eCOA’s capabilities in its vaccine studies, optimizing the patient clinical journey by reducing on-site monitoring and allowing patients to input data in real time from any location. Pilots of eCOA were performed in six vaccine studies and demonstrated high levels of patient compliance, providing highly reliable data. As a result, the collaboration has since moved out of the pilot phase, with eCOA being deployed across a pipeline of Sanofi’s vaccine clinical trials.

“Expanding our collaboration with Medidata will enable us to improve our clinical development processes as we seek to deliver breakthrough vaccines to patients,” said the global head of clinical data management at Sanofi Vaccines. “Through a bespoke eDiary library, we can optimize eDiary set-up and improve data quality in current trials, while moving deeper into the digitalization era within the pharma industry.”

Anthony Costello, chief executive officer, Medidata Patient Cloud, said, “At Medidata, we put the patient at the core of all of our work, and collaborating with Sanofi, who share this ethos, helps improve patient experience, the monitoring of patients in current studies, and accelerate study timelines and efficiencies in future studies.”

Medidata eCOA is a full-service offering revolutionizing the way sponsors, contract research organizations (CROs), and sites collect data from patients, physicians, and caregivers. Built as part of the unified Medidata Platform, eCOA reduces study build times by up to 50% and provides a comprehensive view of patient data, while providing patients with flexibility and choice in how they engage in trial activities.

Sanofi has worked with Medidata for over a decade, leveraging Medidata’s solutions across the organization, including vaccine studies, to securely and efficiently capture and manage data.

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 32,000 trials and 9 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,200+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. The company is a wholly owned subsidiary of Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA), which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization. Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE® Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all – consumers, patients and citizens. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com

©Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries.

Contact:

Medidata PR
Medidata.PR@3ds.com 

Analyst Relations
Medidata.AR@3ds.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/medidata-and-sanofi-vaccines-extend-collaboration-to-improve-patient-centricity-and-trial-efficiency-302075540.html

SOURCE Medidata

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

World IP Day 2026: PitchMark launches Ideas.Exchange to help creators safeguard and license ideas in the age of AI

Published

on

By

SINGAPORE, April 26, 2026 /PRNewswire/ — To mark World IP Day 2026, PitchMark® today launched Ideas.Exchange, a first‑of‑its‑kind platform designed to help creators assert intellectual property rights, license ideas, and formalise creative conversations in an increasingly AI‑driven economy.

Unveiled at Safeguard Your IP in the Age of AI, a media briefing hosted by CNBC’s Sri Jegarajah, the platform responds to growing concern that ideas are routinely used, reused or absorbed without attribution, consent or compensation—often with limited legal or commercial recourse.

“AI has amplified both the reach and the risk for creators,” said Mark Laudi, Managing Partner of PitchMark LLP. “Ideas.Exchange gives creators a way to protect themselves while still participating confidently in the market for ideas.”

At its core, the platform focuses on three interventions for creators:

Asserting IP rights by establishing proof of authorship and precedenceLicensing ideas without giving them away for freeFormalising conversations so pitches and evaluations are governed rather than informal

Ideas.Exchange is powered by three proprietary resources developed by PitchMark. These include a blockchain‑driven clearing house where ideas and creative works can be listed and licensed; smart contracts that automate usage terms and reduce disputes; and an IP Governance Certification Program designed to signal responsible handling of ideas, particularly in enterprise and AI contexts.

The result, PitchMark says, is three concrete outcomes: deterrence of idea theft, new ways to monetise ideas through structured licensing and price discovery, and a more level playing field that allows creators to pitch to clients and platforms on equal terms.

The launch comes amid renewed scrutiny of how intellectual property is treated in the AI era. While idea theft is rarely reported, its impact is significant. Beyond visible financial losses, organisations and creators often absorb hidden costs through talent attrition, innovation suppression and abandoned market opportunities.

“Most idea theft occurs informally and never reaches the courts,” said Prof David Llewelyn, Professor Emeritus of Law at Singapore Management University. “Introducing governance, traceability and standards is a meaningful step toward addressing that gap.”

Spokespeople including Prof Llewelyn, technology lawyer Bryan Ghows, and Mark Laudi are available for interview.

About PitchMark

PitchMark® deters idea theft and enables creatives to get paid by providing a trusted way to share and license ideas with prospects and clients.

 

View original content:https://www.prnewswire.com/apac/news-releases/world-ip-day-2026-pitchmark-launches-ideasexchange-to-help-creators-safeguard-and-license-ideas-in-the-age-of-ai-302753571.html

SOURCE PitchMark

Continue Reading

Technology

SK hynix receives 2026 IEEE Corporate Innovation Award for Driving AI Computing Expansion with HBM

Published

on

By

SK hynix honored at the 2026 IEEE Awards for leading AI technology innovation with HBM Contributed to the global AI computing ecosystem via stable mass production across all HBM generationsCompany committed to becoming a premier leader in AI innovation through collaboration with global customers and partners

SEOUL, South Korea, April 25, 2026 /PRNewswire/ — SK hynix Inc. (or “the company”, www.skhynix.com) announced today that it received the Corporate Innovation Award at the ‘2026 IEEE1 Honors Ceremony’ held in New York on the 24th (local time).

IEEE is the world’s largest technical professional organization dedicated to advancing technology for the benefit of humanity. Established more than a century ago, the IEEE Awards Program recognizes individuals and teams whose innovations have advanced technology and improved the human condition.

The IEEE Corporation Innovation Award, part of the Recognitions category, has been presented since 1986 to companies that have significantly contributed to the advancement of industry and society through innovative technology. This marks the first time SK hynix has received this honor.

SK hynix attributed the honor to its contribution to the global AI computing ecosystem by ensuring the stable mass production of all High Bandwidth Memory (HBM) generations. Looking ahead, the company aims to solidify its position as a trusted partner in the global AI market by providing memory solutions that are critical to overcoming the performance limitations of AI platforms.

The recognition highlights SK hynix’s achievements in driving the expansion of AI computing through HBM innovation and application. Central to this success was the company’s ability to preemptively offer innovative HBM solutions and respond timely to customer demands in the global AI market.

Industry observers also credit this achievement to the strategic direction of SK Group Chairman Chey Tae-won, who has long emphasized securing long-term technological competitiveness. Under his leadership, the company has consistently expanded its AI infrastructure partnerships with global Big Tech firms in the United States.

Ahn Hyun, President and Chief Development Officer (CDO), attended the ceremony as the company representative to accept the award.

“It is an honor to receive this award on behalf of our employees, who have tirelessly challenged the limits of technology,” said Ahn. “By collaborating closely with our global customers and partners, we will stay ahead in creating the value the market demands and continue to be a premier company leading AI innovation.”

About SK hynix Inc.
SK hynix Inc., headquartered in Korea, is the world’s top-tier semiconductor supplier offering Dynamic Random Access Memory chips (“DRAM”) and flash memory chips (“NAND flash”) for a wide range of distinguished customers globally. The Company’s shares are traded on the Korea Exchange, and the Global Depository shares are listed on the Luxembourg Stock Exchange. Further information about SK hynix is available at www.skhynix.com, news.skhynix.com.

About IEEE
IEEE is the world’s largest technical professional organization and a public charity dedicated to advancing technology for the benefit of humanity. Through its highly cited publications, conferences, technology standards, and professional and educational activities, IEEE is the trusted voice in a wide variety of areas ranging from aerospace systems, computers, and telecommunications to biomedical engineering, electric power, and consumer electronics. Learn more at https://www.ieee.org.

View original content:https://www.prnewswire.com/news-releases/sk-hynix-receives-2026-ieee-corporate-innovation-award-for-driving-ai-computing-expansion-with-hbm-302753615.html

SOURCE SK hynix Inc.

Continue Reading

Technology

NCL (Formerly Natural Cure Labs) Unveils New Brand Identity, Reinforcing Its Position as a Leading Monolaurin Supplement Company

Published

on

By

Natural Cure Labs, one of the most recognized monolaurin supplement brands in the United States, is officially transitioning to NCL – the same company, same formulations, and same science-backed standards, under a streamlined name.

ST. PETERSBURG, Fla., April 25, 2026 /PRNewswire-PRWeb/ — Natural Cure Labs, one of the most recognized monolaurin supplement brands in the United States, is officially transitioning to NCL. The company, founded in 2015, is adopting a streamlined brand identity while maintaining the same formulations, manufacturing standards, team, and commitment to quality its customers have trusted for more than a decade.

“NCL represents the quality, transparency, and innovation that our community expects from us. As we enter this new chapter, our commitment to our customers and our standards remains as strong as ever.”

NCL stands for Natural Cure Labs. The name change reflects how customers and the team already refer to the company. Over the past 10+ years, “NCL” has become the natural shorthand for Natural Cure Labs – and this transition formalizes that identity. This is a name change and visual evolution only. Ownership, leadership, formulations, and values remain unchanged.

Same Mission, Sharper Identity

This transition is not a departure from who the company is – it is a natural progression. The values that have guided NCL from the very beginning remain unchanged: clean-label quality, third-party testing, science-backed formulations, and an unwavering commitment to transparency. What is changing is how the company presents itself. In the months ahead, this rebrand will be accompanied by further updates across the brand experience – from visual identity and packaging to how NCL shows up across every channel and platform. Each of these changes will reflect the same standard of excellence customers have come to expect.

What is changing is how the company presents itself. In the months ahead, this rebrand will be accompanied by further updates across the brand experience – from visual identity and packaging to how NCL shows up across every channel and platform. Each of these changes will reflect the same standard of excellence customers have come to expect.

More Than 10 Years of Trust

This evolution comes at a time of significant momentum. Since 2015, NCL has grown from a small startup into an award-winning wellness brand available nationwide through Amazon, Walmart, Target+, TikTok Shop, eBay, and other major marketplaces. Along the way, the company has reached milestones that reflect the trust its community has placed in it:

200,000+ customers served worldwide35+ million capsules sold7,000+ verified customer reviewsRecognition in the 2025 Inc. 5000 list of fastest-growing private companiesMultiple Stevie Awards from the American Business AwardsNamed a 2025 and 2026 Gator100 HonoreeThree-time Global 100 winner for Best Health & Wellness Nutrition Manufacturer

“This rebrand isn’t about changing who we are – it’s about evolving how we present ourselves to match the brand our customers already know and trust,” said Damon Sununtnasuk, Founder & CEO.

What This Means for Customers

For existing customers, nothing changes about the products they know and trust. The same formulations, manufacturing facilities, quality controls, and customer support team remain in place. Products sold as Natural Cure Labs and products sold as NCL are from the same company. Customers can continue to find NCL products on the company’s website and through Amazon, Walmart, Target+, Kroger, eBay, and other major marketplaces.

NCL is grateful for every customer who has been part of this journey and is excited for what is to come.

Media Contact

NCL (Natural Cure Labs), NCL (Natural Cure Labs), 1 8003036214, press@naturalcurelabs.com, https://www.naturalcurelabs.com/

View original content to download multimedia:https://www.prweb.com/releases/ncl-formerly-natural-cure-labs-unveils-new-brand-identity-reinforcing-its-position-as-a-leading-monolaurin-supplement-company-302753477.html

SOURCE NCL (Natural Cure Labs)

Continue Reading

Trending